Journal of Clinical Pharmacology

• 

  Publication Venue For

  • A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers..  59:717-730. 2019
  • Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia..  59:374-385. 2019
  • Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children..  58 Suppl 10:S58-S72. 2018
  • Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children. 2018
  • Population Pharmacokinetics of Dexmedetomidine in Infants..  57:1174-1182. 2017
  • Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects..  57:770-776. 2017
  • Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery..  57:712-719. 2017
  • Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure..  57:440-451. 2017
  • Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation..  57:230-234. 2017
  • Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia..  56:298-306. 2016
  • Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia..  56:176-185. 2016
  • Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.  55:39-44. 2015
  • Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis..  55:39-44. 2015
  • Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF..  54:917-927. 2014
  • Developmental pharmacokinetic changes of Lamivudine in infants and children..  52:1824-1832. 2012
  • Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator..  52:996-1006. 2012
  • Effects of BG9928, an adenosine A₁ receptor antagonist, in patients with congestive heart failure..  51:899-907. 2011
  • Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast..  51:751-760. 2011
  • Pharmacokinetic-pharmacodynamic modeling of apratastat: a population-based approach..  51:472-481. 2011
  • Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide..  50:554-565. 2010
  • In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc..  48:1179-1188. 2008
  • The influence of norfloxacin and metronidazole on the disposition of mycophenolate mofetil..  45:219-226. 2005
  • Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children..  43:133-140. 2003
  • Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers..  42:1027-1030. 2002
  • Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation..  42:388-394. 2002
  • Effect of food and food composition on alcohol elimination rates in healthy men and women.  41:1345-1350. 2001
  • Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system..  40:1141-1149. 2000
  • Oral ondansetron pharmacokinetics: the effect of chemotherapy..  34:767-773. 1994
  • The mechanism of action of steroid hormones: a new twist to an old tale..  33:1165-1172. 1993
  • A 19-YEAR-OLD MAN WITH ALTERED MENTAL STATUS.  32:511-519. 1992
  • A nineteen-year-old man with altered mental status..  32:511-519. 1992
  • Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension..  30:425-437. 1990
  • Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension..  29:33-40. 1989
  • Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy..  27:288-292. 1987
  • EFFECT OF PHENOBARBITAL (PB) ON PHENYTOIN (PHT) BIOTRANSFORMATION DETERMINED BY STABLE ISOTOPE TECHNIQUE.  26:544-544. 1986
  • Combined effect of bumetanide and metolazone in normal volunteers..  25:369-373. 1985
  • Treatment of chronic orthopedic pain with zomepirac..  20:385-391. 1980
  • TREATMENT OF CHRONIC ORTHOPEDIC PAIN WITH ZOMEPIRAC.  20:385-391. 1980
  • Treatment of chronic orthopedic pain with zomepirac.  20:385-391. 1980
  • SIROLIMUS DOSE-NORMALIZED TROUGHS WERE AFFECTED BY TIME POST SIROLIMUS INITIATION, CONCOMITANT TACROLIMUS THERAPY, AND MDR-1 3435C > T POLYMORPHISM IN RENAL TRANSPLANT PATIENTS WHO ARE CYP3A5 NON-EXPRESSERS 2009